StocksUpdated×2•Originally published 20 June 2026•Updated 20 June 2026•
1 min read
Coherent Faces Valuation Test After $50M CHIPS Funding and Stock Surge
Key Facts
1Coherent stock received a warning of being potentially 77% overvalued following its recent price surge.
2The company secured a letter of intent for $50 million in CHIPS Act funding to expand its semiconductor facility.
Frame this as a valuation test for Coherent after a major rally and up to $50 million of CHIPS Act funding for its Indium Phosphide semiconductor facility.
According to Simply Wall Street, its analysis suggests the market price may be about 77% above estimated fair value. Connect federal funding to execution risk and possible AI-spending slowdown instead of unsupported peer/Bloomberg comparisons.
Keep COHR as the only instrument and add EL7’s earlier CHIPS-funding story to also-see because it is the closest direct context.